Market Overview:
The global stroke treatment drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of stroke, rising geriatric population, and technological advancements in the field of stroke treatment drugs. The global stroke treatment drugs market is segmented on the basis of type into anticoagulants, statins, tissue plasminogen activator (tPA), and antiplatelet drugs. The anticoagulants segment is expected to dominate the market during the forecast period owing to its high usage for preventing strokes caused by blood clots. The statins segment is projected to grow at a high rate during the forecast period due to their ability to reduce cholesterol levels and prevent strokes caused by atherosclerosis. On the basis of application, hospitals pharmacies accounted for majority share of revenue in 2017.
Product Definition:
Stroke Treatment Drugs are medications that are used to treat strokes. The main goal of using these drugs is to try and improve the patient's neurological function. Some common stroke treatment drugs include tPA, aspirin, and heparin.
Anticoagulants:
Anticoagulants are substances that reduce the coagulation of blood. Anticoagulants are used in stroke treatment to prevent blood from clotting. They also help to improve the symptoms and may prevent further complications due to stroke. The most common anticoagulant is warfarin which is a type of vitamin K antagonists, it works by decreasing the ability of blood vessels to expand and contract as well as controlling thrombus formation.
Statins:
Statin drugs are the most commonly used medications for stroke treatment. They help reduce bad cholesterol and triglyceride levels in the blood by inhibiting an enzyme called HMG-CoA Reductase. This reduces the production of fatty acids and increases good cholesterol which is protective against a stroke. The American Heart Association recommends that people with cardiovascular diseases should take statins to lower their risk of another attack.
Application Insights:
Based on application, the global stroke treatment drugs market is segmented into hospital pharmacies, retail pharmacies and drug stores, and other pharmacies. Hospital pharmacy held the largest share in 2017 owing to factors such as high usage of anticoagulants for treating strokes at hospitals. In addition, increasing number of stroke patients being treated in hospitals across the world is also expected to drive growth over the forecast period.
The drug store category is expected to witness significant growth during the forecast period due to rising awareness about availability of best quality medicines at affordable prices among general population globally. Increasing use of antiplatelet drugs for preventing blood clots formation after brain injuries or cerebrovascular accidents are also anticipated to boost demand over next seven years.
Regional Analysis:
North America dominated the global stroke treatment drugs market in 2017. This can be attributed to the presence of key players, high healthcare expenditure and improved healthcare infrastructure. In addition, increasing prevalence of stroke is also expected to drive growth during the forecast period. According to data published by Stroke Association in 2018, around 695,000 people are diagnosed with a cerebrovascular disease every year and about 175,000 people die due to it in North America alone.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income leading towards an increase in demand for pharmaceutical products among patients as well as health professionals & public; Increasing awareness regarding risk factors associated with CVDs such as smoking.
Growth Factors:
- Increasing incidence of stroke: The incidence of stroke is increasing globally due to the aging population and rising rates of obesity, hypertension, and diabetes. This is expected to drive the demand for stroke treatment drugs in the coming years.
- Growing awareness about strokes and their prevention: There is a growing awareness among people about strokes and their prevention measures. This is likely to boost the demand for stroke treatment drugs in the near future.
- Technological advancements in drug development: The technological advancements in drug development are helping researchers develop better-quality drugs for treating strokes faster and more effectively. This is likely to fuel market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stroke Treatment Drugs Market Research Report
By Type
Anticoagulants, Statins, Tissue Plasminogen Activator, Antiplatelet Drugs
By Application
Hospital Pharmacies, Drug Stores, Retail Pharmacies
By Companies
Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Abbott, AstraZeneca
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Stroke Treatment Drugs Market Report Segments:
The global Stroke Treatment Drugs market is segmented on the basis of:
Types
Anticoagulants, Statins, Tissue Plasminogen Activator, Antiplatelet Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Pfizer
- Daiichi Sankyo
- Abbott
- AstraZeneca
Highlights of The Stroke Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticoagulants
- Statins
- Tissue Plasminogen Activator
- Antiplatelet Drugs
- By Application:
- Hospital Pharmacies
- Drug Stores
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stroke Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stroke treatment drugs are medications that are used to help improve the symptoms of a stroke. These medications can help reduce the amount of damage done to the brain and may also help improve how well the person recovers from a stroke.
Some of the major companies in the stroke treatment drugs market are Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Abbott, AstraZeneca.
The stroke treatment drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stroke Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stroke Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stroke Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stroke Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stroke Treatment Drugs Market Size & Forecast, 2020-2028
4.5.1 Stroke Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Stroke Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anticoagulants
5.2.2 Statins
5.2.3 Tissue Plasminogen Activator
5.2.4 Antiplatelet Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stroke Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stroke Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anticoagulants
9.6.2 Statins
9.6.3 Tissue Plasminogen Activator
9.6.4 Antiplatelet Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anticoagulants
10.6.2 Statins
10.6.3 Tissue Plasminogen Activator
10.6.4 Antiplatelet Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anticoagulants
11.6.2 Statins
11.6.3 Tissue Plasminogen Activator
11.6.4 Antiplatelet Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anticoagulants
12.6.2 Statins
12.6.3 Tissue Plasminogen Activator
12.6.4 Antiplatelet Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anticoagulants
13.6.2 Statins
13.6.3 Tissue Plasminogen Activator
13.6.4 Antiplatelet Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stroke Treatment Drugs Market: Competitive Dashboard
14.2 Global Stroke Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Bristol-Myers Squibb
14.3.3 Pfizer
14.3.4 Daiichi Sankyo
14.3.5 Abbott
14.3.6 AstraZeneca
